145 related articles for article (PubMed ID: 30183467)
1. End-of-Life Care Intensity in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: A Population-Level Analysis.
Johnston EE; Muffly L; Alvarez E; Saynina O; Sanders LM; Bhatia S; Chamberlain LJ
J Clin Oncol; 2018 Oct; 36(30):3023-3030. PubMed ID: 30183467
[TBL] [Abstract][Full Text] [Related]
2. Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Cappell K; Sundaram V; Park A; Shiraz P; Gupta R; Jenkins P; Periyakoil VSJ; Muffly L
Biol Blood Marrow Transplant; 2018 May; 24(5):1035-1040. PubMed ID: 29371107
[TBL] [Abstract][Full Text] [Related]
3. End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Salazar MM; DeCook LJ; Butterfield RJ; Zhang N; Sen A; Wu KL; Vanness DJ; Khera N
J Palliat Med; 2022 Jan; 25(1):97-105. PubMed ID: 34705545
[No Abstract] [Full Text] [Related]
4. Disparities in Inpatient Intensity of End-of-Life Care for Complex Chronic Conditions.
Johnston EE; Bogetz J; Saynina O; Chamberlain LJ; Bhatia S; Sanders L
Pediatrics; 2019 May; 143(5):. PubMed ID: 30971431
[TBL] [Abstract][Full Text] [Related]
5. Healthcare Utilization is High in Adult Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation.
Langston JA; Sundaram V; Periyakoil VS; Muffly L
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1659-1665. PubMed ID: 30959162
[TBL] [Abstract][Full Text] [Related]
6. Disparities in the Intensity of End-of-Life Care for Children With Cancer.
Johnston EE; Alvarez E; Saynina O; Sanders L; Bhatia S; Chamberlain LJ
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28963112
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.
Bayraktar UD; Shpall EJ; Liu P; Ciurea SO; Rondon G; de Lima M; Cardenas-Turanzas M; Price KJ; Champlin RE; Nates JL
J Clin Oncol; 2013 Nov; 31(33):4207-14. PubMed ID: 24127454
[TBL] [Abstract][Full Text] [Related]
8. Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life.
Snaman JM; Talleur AC; Lu J; Levine DR; Kaye EC; Sykes A; Lu Z; Triplett BM; Baker JN
Bone Marrow Transplant; 2018 Jan; 53(1):84-90. PubMed ID: 29131155
[TBL] [Abstract][Full Text] [Related]
9. End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant.
Ullrich CK; Lehmann L; London WB; Guo D; Sridharan M; Koch R; Wolfe J
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1049-1055. PubMed ID: 26903381
[TBL] [Abstract][Full Text] [Related]
10. End-of-Life Intensity for Adolescents and Young Adults With Cancer: A Californian Population-Based Study That Shows Disparities.
Johnston EE; Alvarez E; Saynina O; Sanders L; Bhatia S; Chamberlain LJ
J Oncol Pract; 2017 Sep; 13(9):e770-e781. PubMed ID: 28829692
[TBL] [Abstract][Full Text] [Related]
11. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
Lin RJ; Cohen AG; Stabler SM; Devlin SM; Elko TA; Maloy MA; Korc-Grodzicki B; Alexander K; Kramer D; Sanchez-Escamilla M; Castillo Flores N; Barker JN; Cho C; Dahi PB; Gyurkocza B; Papadopoulos EB; Perales MA; Politikos I; Ponce DM; Sauter CS; Scordo M; Shaffer BC; Shah GL; Tamari R; Young JW; Jakubowski AA; Giralt SA; Nelson JE
J Palliat Med; 2020 Dec; 23(12):1653-1657. PubMed ID: 32216649
[No Abstract] [Full Text] [Related]
13. Impact of comorbidities constituting the hematopoietic cell transplant (HCT)-comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia.
Khalil MMI; Lipton JH; Atenafu EG; Gupta V; Kim DD; Kuruvilla J; Viswabandya A; Messner HA; Michelis FV
Eur J Haematol; 2018 Feb; 100(2):198-205. PubMed ID: 29168234
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.
Veeraputhiran M; Yang L; Sundaram V; Arai S; Lowsky R; Miklos D; Meyer E; Muffly L; Negrin R; Rezvani A; Shizuru J; Weng WK; Johnston L
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1744-1748. PubMed ID: 28668491
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34
Barba P; Ratan R; Cho C; Ceberio I; Hilden P; Devlin SM; Maloy MA; Barker JN; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Ponce DM; Sauter C; Tamari R; van den Brink MRM; Young JW; O'Reilly RJ; Giralt SA; Perales MA
Biol Blood Marrow Transplant; 2017 Jan; 23(1):67-74. PubMed ID: 27789361
[TBL] [Abstract][Full Text] [Related]
18. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
[TBL] [Abstract][Full Text] [Related]
19. Weight gain and supplemental O
Rowan CM; Nitu ME; Moser EAS; Swigonski NL; Renbarger JL
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28439949
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Hematopoietic Cell Transplant Patients Who Survive Critical Illness Frequently Have Significant but Recoverable Decline in Functional Status.
Zinter MS; Holubkov R; Steurer MA; Dvorak CC; Duncan CN; Sapru A; Tamburro RF; McQuillen PS; Pollack MM
Biol Blood Marrow Transplant; 2018 Feb; 24(2):330-336. PubMed ID: 29128553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
